Convergentgenomics
Founded 2015 · 25 employees on LinkedIn · 1 known investors
Find your way into Convergentgenomics
38 people in our graph share verified history with the Convergentgenomics team — schools, employers, funds. One of them is your warm intro.
Janelle Goulardunlockedknows Trevor Levin · together at Oregon Health & Science University (overlapped)
×6knows the team · via Oregon Health & Science University
knows the team · via Convergentgenomics
×4knows the team · via Willamette University
Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.
Founders & leadership
Convergentgenomics was founded in 2015 by Trevor Levin.
TL
Trevor LevininFounder, President & Chief Scientific OfficerTrevor Levin is founder and chief scientific officer of Convergent Genomics, a genomic diagnostics company developing next-generation sequencing and liquid biopsy tests for early detection of urothelial cancer. His expertise spans genomic analysis, computational biology, and drug response prediction applied to cancer diagnostics and treatment development.
BS
Brian SlingerlandinChief Executive Officer
BM
Brian MazzarellaChief Medical Officer
IH
Iden HaddadzadehChief Operating Officer
Investors · 1
Competitors · 2
by search overlap
Labcorp33 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Ubie29 shared keywordsUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
Companies competing with Convergentgenomics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Convergentgenomics do?
- Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.
- Who founded Convergentgenomics?
- Convergentgenomics was founded by Trevor Levin in 2015.
- Who are Convergentgenomics's investors?
- Convergentgenomics's investors include Civilization Ventures Management, Llc.